Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors
Authors:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (12) , 3502-3511
Abstract
Alternative splicing facilitates the splicing of precursor RNA into different isoforms. Alternatively spliced transcripts often exhibit antagonistic functions or differential temporal or spatial expression patterns. There is increasing evidence that alternative splicing, especially by the serine-arginine rich (SR) protein family, leads to abnormal expression patterns and is closely related to the development of cancer. SRSF3, also known as SRp20, is a splicing factor. Through alternative splicing, it plays important roles in regulating various biological functions, such as cell cycle, cell proliferation, migration and invasion, under pathological and physiological conditions. Deregulation of SRSF3 is an essential feature of cancers. SRSF3 is also considered a candidate therapeutic target. Therefore, the involvement of abnormal splicing in tumorigenesis and the regulation of splicing factors deserve further analysis and discussion. Here, we summarize the function of SRSF3-regulated alternative transcripts in cancer cell biology at different stages of tumor development and the regulation of SRSF3 in tumorigenesis.Keywords
This publication has 100 references indexed in Scilit:
- Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exonsJournal of Molecular Cell Biology, 2011
- DARPP-32 Increases Interactions Between Epidermal Growth Factor Receptor and ERBB3 to Promote Tumor Resistance to GefitinibGastroenterology, 2011
- Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancerOncogene, 2010
- Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesisSurgery, 2010
- The SR protein family of splicing factors: master regulators of gene expressionBiochemical Journal, 2008
- The emerging role of splicing factors in cancerEMBO Reports, 2008
- Function and regulation of protein neddylationEMBO Reports, 2008
- HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesisProceedings of the National Academy of Sciences, 2007
- A nucleo‐cytoplasmic SR protein functions in viral IRES‐mediated translation initiationThe EMBO Journal, 2006
- Inactivation of the SR Protein Splicing Factor ASF/SF2 Results in Genomic InstabilityCell, 2005